Ivan Segawa
Overview
Explore the profile of Ivan Segawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ndagire R, Obuku E, Segawa I, Atim F, Lwanira C, Wangi R, et al.
Antimicrob Resist Infect Control
. 2025 Feb;
14(1):12.
PMID: 39985071
Background: Antimicrobial resistance (AMR) remains a public health threat especially in low-and-middle-income countries (LMICs). Urban slum dwellers are at higher risk of developing AMR than the general population. The aim...
2.
Mpirirwe R, Segawa I, Ojiambo K, Kamacooko O, Nangendo J, Semitala F, et al.
BMJ Open
. 2024 Apr;
14(4):e076545.
PMID: 38670600
Objective: To evaluate oral pre-exposure prophylaxis (PrEP) uptake, retention and adherence among female sex workers (FSWs) receiving care through community and facility delivery models in sub-Saharan Africa (SSA). Design: Systematic...
3.
Musiime V, Rujumba J, Kakooza L, Namisanvu H, Atuhaire L, Naguti E, et al.
PLoS One
. 2024 Apr;
19(4):e0301887.
PMID: 38626109
Background: Despite global efforts to eliminate mother-to-child-transmission of HIV (MTCT), many children continue to become infected. We determined the prevalence of HIV among children with severe acute malnutrition (SAM) and...
4.
Ojiambo K, Nakku J, Wangi R, Segawa I, Ndagire R, Nangendo J, et al.
BMJ Open
. 2023 Oct;
13(10):e073623.
PMID: 37899147
Objective: This study aimed to determine the socio-demographic and clinical characteristics associated with retention in care and reasons for loss to follow-up (LTFU) among people living with HIV (PLWH) with...
5.
Kirenga B, Mugenyi L, Sanchez-Rico M, Kyobe H, Muttamba W, Mugume R, et al.
Mol Psychiatry
. 2023 Mar;
28(12):5411-5418.
PMID: 36869228
Prior research suggests that fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) used for the treatment of obsessive-compulsive disorder and major depressive disorder, could be repurposed against COVID-19. We undertook a...
6.
Segawa I, Bakeera-Kitaka S, Ssebambulidde K, Muwonge T, Oriokot L, Ojiambo K, et al.
AIDS Res Ther
. 2022 Dec;
19(1):59.
PMID: 36457098
Background: Adolescent girls and young women (AGYW) at institutions of higher learning are at high risk of HIV, and conventional HIV testing services may not reach them sufficiently. HIV self-testing...
7.
Ssebambulidde K, Kayiira A, Segawa I, Namanda S, Nakibuuka V, Musiime V, et al.
BMC Pediatr
. 2022 Jul;
22(1):434.
PMID: 35858938
Background: Many aspects of microbial dissemination appear to vary with host cholesterol levels. Since neonatal septicemia remains a leading cause of newborn admissions and mortality in resource-limited settings, the contribution...
8.
Musiime V, Kiggwe A, Beinomugisha J, Kakooza L, Thembo-Mwesige J, Nkinzi S, et al.
Front Pediatr
. 2022 Jul;
10:880355.
PMID: 35813373
Background: Children living with HIV (CLHIV) and children who are exposed to HIV but uninfected (CHEU) are at increased risk of developing malnutrition. Severely malnourished children have high mortality rates,...
9.
Ssebambulidde K, Segawa I, Laker E, Lamorde M, Castelnuovo B, Nakasujja N, et al.
Oxf Med Case Reports
. 2020 Jul;
2020(6):omz121.
PMID: 32617171
[This corrects the article DOI: 10.1093/omcr/omy132.].
10.
Ssebambulidde K, Segawa I, Laker E, Lamorde M, Castelnouvo B, Nakasujja N, et al.
Oxf Med Case Reports
. 2019 Feb;
2019(2):omy132.
PMID: 30800328
Two HIV-infected individuals on second-line atazanavir-based antiretroviral therapy presented with neuropsychiatric symptoms. Cerebrospinal fluid HIV RNA was higher than plasma HIV RNA and antiretroviral regimens' optimization led to prompt resolution...